NM_001082486.2:c.22G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001082486.2(ACD):​c.22G>A​(p.Val8Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000577 in 1,612,648 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V8V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00062 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 4 hom. )

Consequence

ACD
NM_001082486.2 missense

Scores

2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6O:1

Conservation

PhyloP100: 0.0570

Publications

9 publications found
Variant links:
Genes affected
ACD (HGNC:25070): (ACD shelterin complex subunit and telomerase recruitment factor) This gene encodes a protein that is involved in telomere function. This protein is one of six core proteins in the telosome/shelterin telomeric complex, which functions to maintain telomere length and to protect telomere ends. Through its interaction with other components, this protein plays a key role in the assembly and stabilization of this complex, and it mediates the access of telomerase to the telomere. Multiple transcript variants encoding different isoforms have been found for this gene. This gene, which is also referred to as TPP1, is distinct from the unrelated TPP1 gene on chromosome 11, which encodes tripeptidyl-peptidase I. [provided by RefSeq, Jul 2008]
ACD Gene-Disease associations (from GenCC):
  • dyskeratosis congenita, autosomal dominant 6
    Inheritance: AR, AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hereditary isolated aplastic anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009870857).
BP6
Variant 16-67660199-C-T is Benign according to our data. Variant chr16-67660199-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 434071.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000572 (836/1460304) while in subpopulation MID AF = 0.029 (167/5768). AF 95% confidence interval is 0.0254. There are 4 homozygotes in GnomAdExome4. There are 434 alleles in the male GnomAdExome4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACDNM_001082486.2 linkc.22G>A p.Val8Ile missense_variant Exon 1 of 12 ENST00000620761.6 NP_001075955.2 Q96AP0-3
ACDNM_022914.3 linkc.22G>A p.Val8Ile missense_variant Exon 1 of 12 NP_075065.3 Q96AP0-2
ACDNM_001410884.1 linkc.22G>A p.Val8Ile missense_variant Exon 1 of 11 NP_001397813.1
ACDXR_429728.4 linkn.62G>A non_coding_transcript_exon_variant Exon 1 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACDENST00000620761.6 linkc.22G>A p.Val8Ile missense_variant Exon 1 of 12 1 NM_001082486.2 ENSP00000478084.1 Q96AP0-3

Frequencies

GnomAD3 genomes
AF:
0.000624
AC:
95
AN:
152226
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000747
AC:
181
AN:
242180
AF XY:
0.000748
show subpopulations
Gnomad AFR exome
AF:
0.000470
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00183
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000718
Gnomad OTH exome
AF:
0.00237
GnomAD4 exome
AF:
0.000572
AC:
836
AN:
1460304
Hom.:
4
Cov.:
34
AF XY:
0.000597
AC XY:
434
AN XY:
726444
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33472
American (AMR)
AF:
0.00114
AC:
51
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00199
AC:
52
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.000823
AC:
71
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52010
Middle Eastern (MID)
AF:
0.0290
AC:
167
AN:
5768
European-Non Finnish (NFE)
AF:
0.000355
AC:
395
AN:
1111892
Other (OTH)
AF:
0.00124
AC:
75
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000624
AC:
95
AN:
152344
Hom.:
2
Cov.:
33
AF XY:
0.000658
AC XY:
49
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41578
American (AMR)
AF:
0.00176
AC:
27
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68032
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00117
Hom.:
11
Bravo
AF:
0.000680
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000685
AC:
3
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000776
AC:
94
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00172

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACD: BP4 -

Apr 07, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

not specified Uncertain:1Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Classification criteria: BP4_strong -

Jan 09, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dyskeratosis congenita, autosomal dominant 6 Uncertain:1Other:1
-
GenomeConnect - Invitae Patient Insights Network
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Uncertain significance and reported on 04-25-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 94 of the ACD protein (p.Val94Ile). This variant is present in population databases (rs149365469, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with dyskeratosis congenita–like phenotype (PMID: 30064976). ClinVar contains an entry for this variant (Variation ID: 434071). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ACD protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects ACD function (PMID: 30064976). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Mar 24, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.280G>A (p.V94I) alteration is located in exon 1 (coding exon 1) of the ACD gene. This alteration results from a G to A substitution at nucleotide position 280, causing the valine (V) at amino acid position 94 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

ACD-related disorder Benign:1
May 26, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;T;T;T;T;.
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.67
T;T;.;T;T;.
MetaRNN
Benign
0.0099
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
.;L;.;.;.;L
PhyloP100
0.057
PrimateAI
Benign
0.48
T
REVEL
Benign
0.019
Sift4G
Uncertain
0.031
.;D;D;.;T;.
Polyphen
0.35, 0.30
.;B;.;.;.;B
Vest4
0.088, 0.13, 0.15
MVP
0.15
MPC
0.14
ClinPred
0.015
T
GERP RS
3.5
PromoterAI
0.066
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.13
gMVP
0.094
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149365469; hg19: chr16-67694102; API